Recursion Pharmaceuticals (RXRX) announced that Vicki Goodman will become Recursion’s chief medical officer effective April 6 as David Mauro transitions out of the role. Previously, she was executive VP, product development and medical affairs and chief medical officer at Exelixis (EXEL).
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RXRX: